Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$2.28M Buy
7,299
+1,500
+26% +$441K 2.04% 8
2024
Q1
$1.65M Hold
5,799
1.51% 20
2023
Q4
$1.67M Hold
5,799
1.54% 17
2023
Q3
$1.56M Buy
5,799
+3,217
+125% +$803K 1.47% 18
2023
Q2
$573K Buy
2,582
+2,500
+3,049% +$580K 0.52% 42
2023
Q1
$19.8K Hold
82
0.02% 210
2022
Q4
$21.5K Hold
82
0.02% 191
2022
Q3
$18K Hold
82
0.02% 224
2022
Q2
$20K Hold
82
0.02% 222
2022
Q1
$20K Hold
82
0.02% 234
2021
Q4
$18K Sell
82
-8,480
-99% -$1.79M 0.02% 258
2021
Q3
$1.82M Buy
8,562
+659
+8% +$152K 1.61% 22
2021
Q2
$1.93M Buy
+7,903
New +$1.94M 1.68% 19

Other funds holding AMGN

EMFO LLC's AMGN Position: Q2 2024 in Review

EMFO LLC increased its Amgen (AMGN) stake by 26% in Q2 2024, buying an estimated $441K and bringing the position to 7,299 shares worth $2.28M. The position accounts for 2.04% of the portfolio, ranked #8.

EMFO LLC first reported a position in AMGN in Q2 2021 and has held it in 13 quarters since. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • EMFO LLC held 7,299 shares of Amgen worth $2.28M as of Q2 2024.
  • EMFO LLC bought 1,500 Amgen shares in Q2 2024, an estimated $441K.
  • Amgen made up 2.04% of EMFO LLC's portfolio in Q2 2024, its #8 holding.
  • EMFO LLC first reported a position in Amgen in Q2 2021 and has held it in 13 quarters since.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.